PHASE-II TRIAL OF DIDOX IN ADVANCED BREAST-CANCER

被引：33
|
作者：
RUBENS, RD
KAYE, SB
SOUKOP, M
WILLIAMS, CJ
BRAMPTON, MH
HARRIS, AL
机构：
[1] WESTERN INFIRM & ASSOCIATED HOSP,BEATSON ONCOL CTR,W SCOTLAND CLIN TRIALS UNIT,GLASGOW G12 0NY,SCOTLAND
[2] GLASGOW ROYAL INFIRM,GLASGOW G4 0FF,SCOTLAND
[3] SOUTHAMPTON GEN HOSP,CANC RES CAMPAIGN,MED ONCOL UNIT,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND
[4] CHARING CROSS HOSP,DEPT MED ONCOL,CANC RES CAMPAIGN,CTR PHASE 1-2 DATA,LONDON W6 8RF,ENGLAND
[5] CHURCHILL HOSP,IMPERIAL CANC RES FUND,DEPT CLIN ONCOL,OXFORD OX3 7LJ,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1991年 / 64卷 / 06期
关键词：
D O I：
10.1038/bjc.1991.488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Fourteen patients with advanced breast cancer were treated with the ribonucleotide reductase inhibitor didox 6 g m-2 given by intravenous infusion over 36 h every 3 weeks. None responded and toxicity was minimal. Possibilities for the more effective use of this agent are discussed.
引用
收藏
页码：1187 / 1188
页数：2
相关论文
共 50 条
  • [31] PHASE-II STUDY OF ANGUIDINE IN ADVANCED BREAST-CANCER
    YAP, HY
    MURPHY, WK
    DISTEFANO, A
    BLUMENSCHEIN, GR
    BODEY, GP
    CANCER TREATMENT REPORTS, 1979, 63 (05): : 789 - 791
  • [32] IDARUBICIN IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    LIONETTO, R
    PRONZATO, P
    CONTE, PF
    SERTOLI, MR
    AMOROSO, D
    ROSSO, R
    CANCER TREATMENT REPORTS, 1986, 70 (12): : 1439 - 1440
  • [33] A PHASE-II STUDY OF MITOXANTRONE IN ADVANCED BREAST-CANCER
    PRONZATO, P
    ARDIZZONI, A
    CONTE, PF
    GULISANO, M
    LIONETTO, R
    REPETTO, L
    SCORNAVACCHE, V
    SERTOLI, MR
    ROSSO, R
    CHEMIOTERAPIA, 1986, 5 (03): : 150 - 153
  • [34] PHASE-II STUDY OF TENIPOSIDE IN ADVANCED BREAST-CANCER
    BOAS, J
    RASMUSSEN, D
    HANSEN, OP
    ENGELHOLM, SA
    DOMBERNOWSKY, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) : 463 - 464
  • [35] CISPLATIN PLUS VINDESINE IN ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE EORTC BREAST-CANCER COOPERATIVE GROUP
    PARIDAENS, R
    CLARYSSE, A
    ROZENCWEIG, M
    ROTMENSZ, N
    HEUSON, JC
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (05): : 595 - 599
  • [36] PHASE-II TRIAL OF AMSA IN REFRACTORY BREAST-CANCER
    DELENA, M
    ROSSI, A
    BONADONNA, G
    CANCER TREATMENT REPORTS, 1982, 66 (02): : 403 - 404
  • [37] PHASE-II TRIAL OF REFRACTORY ADVANCED BREAST-CANCER WITH THE PROSORBA PROTEIN-A COLUMNS
    MESSERSCHMIDT, GL
    CLINICAL RESEARCH, 1986, 34 (02): : A567 - A567
  • [38] PHASE-II TRIAL OF HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
    SCINTO, AF
    CERCATO, MC
    BOTTI, C
    TONACHELLA, R
    FERRARESI, V
    DELBIANCO, S
    SACCHI, I
    COGNETTI, F
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1285 - 1288
  • [39] PHASE-II TRIAL OF ORAL IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED BREAST-CANCER
    WANDER, HE
    MEYER, D
    SCHUFFWERNER, P
    NAGEL, GA
    ONKOLOGIE, 1986, 9 (04): : 236 - 238
  • [40] RANDOMIZED PHASE-II TRIAL OF CARMINOMYCIN VERSUS 4'-EPIDOXORUBICIN IN ADVANCED BREAST-CANCER
    ROZENCWEIG, M
    HUININK, WT
    CAVALLI, F
    BRUNTSCH, U
    DOMBERNOWSKY, P
    HOST, H
    BRAMWELL, V
    RENARD, G
    VANGLABBEKE, M
    DECOSTER, G
    CLARYSSE, A
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (04) : 275 - 281
12345